US6410010B1
(en)
*
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
CA2108144A1
(en)
|
1991-03-06 |
1992-09-07 |
Jack A. Roth |
Methods and compositions for the selective inhibition of gene expression
|
WO1994029471A1
(en)
*
|
1993-06-10 |
1994-12-22 |
Genetic Therapy, Inc. |
Adenoviral vectors for treatment of hemophilia
|
US7252989B1
(en)
*
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
ATE336587T1
(de)
|
1994-06-10 |
2006-09-15 |
Genvec Inc |
Adenoviren-vektor systeme und zelllinien
|
US5851806A
(en)
*
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
ATE246252T1
(de)
*
|
1994-08-16 |
2003-08-15 |
Crucell Holland Bv |
Von adenovirus abgeleitete rekombinante vektoren, für gentherapie
|
FR2723697B1
(fr)
*
|
1994-08-17 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Methode de traitement de la restenose par la therapie genique
|
US5856152A
(en)
*
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
CA2203809C
(en)
*
|
1994-10-28 |
2008-06-03 |
James M. Wilson |
Recombinant adenovirus and methods of use thereof
|
FR2727867B1
(fr)
*
|
1994-12-13 |
1997-01-31 |
Rhone Poulenc Rorer Sa |
Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux
|
FR2741891B1
(fr)
*
|
1995-06-01 |
1998-01-09 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
FR2738575B1
(fr)
*
|
1995-09-08 |
1997-10-10 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
FR2729674B1
(fr)
*
|
1995-01-20 |
1997-04-11 |
Centre Nat Rech Scient |
Cellules pour la production d'adenovirus recombinants
|
IL116816A
(en)
*
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
FR2730504B1
(fr)
|
1995-02-13 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Procede de preparation de genomes d'adenovirus recombinants
|
US5637456A
(en)
*
|
1995-02-17 |
1997-06-10 |
The University Of Texas, Board Of Regents |
Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
US6752987B1
(en)
|
1995-02-28 |
2004-06-22 |
The Regents Of The University Of California |
Adenovirus encoding human adenylylcyclase (AC) VI
|
WO1996026742A1
(en)
|
1995-02-28 |
1996-09-06 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
FR2731710B1
(fr)
*
|
1995-03-14 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
Virus recombinants exprimant la lecithine cholesterol acyltransferase et utilisations en therapie genique
|
JP3770333B2
(ja)
*
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えdnaウイルスおよびその製造方法
|
US5707618A
(en)
*
|
1995-03-24 |
1998-01-13 |
Genzyme Corporation |
Adenovirus vectors for gene therapy
|
FR2732357B1
(fr)
*
|
1995-03-31 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose
|
DE69628744D1
(de)
*
|
1995-04-17 |
2003-07-24 |
Univ Texas System Austin Board |
Adenovirus helfervirus system
|
FR2734826B1
(fr)
*
|
1995-06-01 |
1997-07-04 |
Rhone Poulenc Rorer Sa |
Deltap62, ses variants, sequences nucleiques et leurs utilisations
|
AU6261696A
(en)
|
1995-06-05 |
1996-12-24 |
Trustees Of The University Of Pennsylvania, The |
A replication-defective adenovirus human type 5 recombinant as a vaccine carrier
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US5698202A
(en)
*
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
US5756283A
(en)
*
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US6783980B2
(en)
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
US6265212B1
(en)
|
1995-06-15 |
2001-07-24 |
Introgene B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
DE69633565T3
(de)
*
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
WO1997000954A1
(en)
*
|
1995-06-23 |
1997-01-09 |
Board Of Regents, The University Of Texas System |
C-cam expression constructs and their application in cancer therapy
|
FR2735789B1
(fr)
|
1995-06-23 |
1997-07-25 |
Centre Nat Rech Scient |
Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
|
FR2737222B1
(fr)
*
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux et lignee pour la therapie genique
|
FR2737221B1
(fr)
*
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux pour la therapie genique
|
AUPN477695A0
(en)
*
|
1995-08-14 |
1995-09-07 |
Commonwealth Scientific And Industrial Research Organisation |
Gene therapy
|
US6482803B1
(en)
|
1995-09-01 |
2002-11-19 |
Board Of Regents, The University Of Texas System |
Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
|
AU7674896A
(en)
*
|
1995-10-31 |
1997-05-22 |
Board Of Regents, The University Of Texas System |
Adenovirus-antisense k-ras expression vectors and their application in cancer therapy
|
JP2006075171A
(ja)
*
|
1995-11-09 |
2006-03-23 |
Avigen Inc |
組換えaavビリオン産生における使用のための補助機能
|
US6004797A
(en)
*
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
EP0862644A2
(de)
*
|
1995-11-17 |
1998-09-09 |
Franz, Wolfgang-M., Dr. |
Gentherapeutisches nukleinsäurekonstrukt, seine herstellung und verwendung zur behandlung von herzerkrankungen
|
FR2746110B1
(fr)
*
|
1996-03-14 |
1998-04-17 |
|
Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants
|
US6132989A
(en)
*
|
1996-06-03 |
2000-10-17 |
University Of Washington |
Methods and compositions for enhanced stability of non-adenoviral DNA
|
US20040156861A1
(en)
|
1996-07-11 |
2004-08-12 |
Figdor Carl Gustav |
Melanoma associated peptide analogues and vaccines against melanoma
|
US5958892A
(en)
|
1996-07-30 |
1999-09-28 |
Board Of Regents, The University Of Texas System |
2-methoxyestradiol-induced apoptosis in cancer cells
|
WO1998010087A1
(en)
*
|
1996-09-06 |
1998-03-12 |
Trustees Of The University Of Pennsylvania |
Chimpanzee adenovirus vectors
|
NZ334827A
(en)
*
|
1996-09-25 |
2001-02-23 |
Scripps Research Inst |
High-capacity adenoviral vectors suitable for adenoviral-based gene therapy
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
CZ299055B6
(cs)
|
1996-12-06 |
2008-04-09 |
Aventis Pharmaceuticals Inc. |
Izolovaný polypeptid kódovaný genem podobným genupro lipázu, prostredek mající fosfolipázovou úcinnost, farmaceutický prostredek, izolovaný imunizacní peptid a nukleová kyselina, biologicky aktivní prostredek, vektor, rekombinantní bunka, prostredek
|
US7008776B1
(en)
|
1996-12-06 |
2006-03-07 |
Aventis Pharmaceuticals Inc. |
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
|
WO1998032860A1
(en)
*
|
1997-01-28 |
1998-07-30 |
Baxter International Inc. |
Methods for highly efficient generation of adenoviral vectors
|
US6403370B1
(en)
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
CN1177934C
(zh)
|
1997-04-28 |
2004-12-01 |
阿文蒂斯药物股份有限公司 |
腺病毒介导的肿瘤内投送血管生成拮抗剂用于肿瘤的治疗
|
AUPO856097A0
(en)
|
1997-08-14 |
1997-09-04 |
Commonwealth Scientific And Industrial Research Organisation |
Vector
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
US6875606B1
(en)
|
1997-10-23 |
2005-04-05 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Human α-7 nicotinic receptor promoter
|
US6653088B1
(en)
|
1997-10-24 |
2003-11-25 |
Aventis Pharma S.A. |
Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the β-amyloid peptide
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
ATE302267T1
(de)
|
1998-01-08 |
2005-09-15 |
Aventis Pharma Inc |
Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
|
EP1047784B2
(de)
|
1998-01-14 |
2015-03-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigene aus neisseria meningitidis
|
US6670188B1
(en)
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
NZ532665A
(en)
|
1998-05-01 |
2005-11-25 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
WO2000012740A2
(en)
*
|
1998-08-28 |
2000-03-09 |
Duke University |
ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
|
US6441156B1
(en)
*
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
US6291226B1
(en)
*
|
1999-02-25 |
2001-09-18 |
National Research Council Of Canada |
Adenovirus mutants with deleted protease gene
|
SI1161548T2
(sl)
*
|
1999-04-15 |
2010-02-26 |
Crucell Holland Bv |
Priprava rekombinantnega proteina v humani celici z uporabo sekvenc, ki kodirajo adenovirusni E1 protein
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6793926B1
(en)
|
1999-05-27 |
2004-09-21 |
Genovo, Inc. |
Methods for production of a recombinant adeno-associated virus
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
FR2799472B1
(fr)
|
1999-10-07 |
2004-07-16 |
Aventis Pharma Sa |
Preparation d'adenovirus recombinants et de banques adenovirales
|
EP2975127A1
(de)
|
1999-10-29 |
2016-01-20 |
GlaxoSmithKline Biologicals SA |
Neisseria antigenpeptide
|
AU2460001A
(en)
|
1999-12-27 |
2001-07-09 |
Regents Of The University Of California, The |
Gene therapy for congestive heart failure
|
EP2275129A3
(de)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
|
WO2001074900A2
(en)
|
2000-03-31 |
2001-10-11 |
Aventis Pharmaceuticals Products Inc. |
Nuclear factor kb inducing factor
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
US7125549B2
(en)
*
|
2000-05-31 |
2006-10-24 |
Human Gene Therapy Research Institute |
Methods and compositions for efficient gene transfer using transcomplementary vectors
|
SG165981A1
(en)
|
2000-10-27 |
2010-11-29 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
US7060442B2
(en)
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
DE60144198D1
(de)
|
2000-12-28 |
2011-04-21 |
Wyeth Llc |
Rekombinantes schutzprotein aus streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
AUPR518501A0
(en)
|
2001-05-22 |
2001-06-14 |
Unisearch Limited |
Yin yang-1
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
US7569217B2
(en)
|
2001-09-24 |
2009-08-04 |
University Of Saskatchewan |
Porcine adenovirus E1 and E4 regions
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
EP2335723A1
(de)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisierung gegen Chlamydia trachomatis
|
US20030232018A1
(en)
*
|
2002-01-18 |
2003-12-18 |
Berlex Biosciences |
Stabilized formulations of adenovirus
|
US7319001B2
(en)
|
2002-03-09 |
2008-01-15 |
Neurogenex Co., Ltd. |
High throughput system for producing recombinant viruses using site-specific recombination
|
WO2003100008A2
(en)
|
2002-05-24 |
2003-12-04 |
Schering Corporation |
Neutralizing human anti-igfr antibody
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
CA2421269A1
(en)
|
2002-08-09 |
2004-02-09 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
RU2244928C2
(ru)
*
|
2003-02-19 |
2005-01-20 |
Пинигина Нина Максимовна |
Эндогенная фармацевтическая композиция, полученная на основе целенаправленной активации гуморальных медиаторов нервных окончаний коры головного мозга
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
WO2005051432A1
(en)
|
2003-11-14 |
2005-06-09 |
Genvec, Inc. |
Therapeutic regimen for treating cancer
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
CN104292321A
(zh)
|
2004-03-29 |
2015-01-21 |
株式会社嘉尔药物 |
新的半乳凝素9 突变体蛋白质及其用途
|
CN1972958B
(zh)
|
2004-04-12 |
2013-01-23 |
美国政府卫生与公共服务部 |
应用腺病毒载体诱导免疫应答的方法
|
CA2836987C
(en)
|
2004-05-26 |
2016-07-05 |
Psioxus Therapeutics Limited |
Chimeric adenoviruses for use in cancer treatment
|
CN101087879B
(zh)
|
2004-06-18 |
2013-08-14 |
杜克大学 |
气味受体的调控剂
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
CA2573702C
(en)
|
2004-07-16 |
2013-10-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Vaccine constructs and combination of vaccines designed to improve the breadth of the immune response to diverse strains and clades of hiv
|
WO2006039045A2
(en)
*
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
EP3002330A1
(de)
|
2005-05-27 |
2016-04-06 |
Ospedale San Raffaele S.r.l. |
Genvektor
|
EP1929021A2
(de)
|
2005-08-31 |
2008-06-11 |
Genvec, Inc. |
Malariaimpfstoffe auf adenovirusvektorbasis
|
BRPI0618441B8
(pt)
|
2005-11-10 |
2021-07-27 |
Genvec Inc |
vetor adenoviral
|
ATE522541T1
(de)
|
2006-06-09 |
2011-09-15 |
Novartis Ag |
Bakterielle adhäsine konformere
|
RU2500815C2
(ru)
|
2006-07-28 |
2013-12-10 |
Санофи-Авентис |
Композиция и способ лечения опухолей
|
ES2388567T3
(es)
|
2006-10-19 |
2012-10-16 |
Csl Limited |
Anticuerpos anti-il-13r alfa 1 y usos de los mismos
|
WO2008060813A2
(en)
|
2006-10-19 |
2008-05-22 |
Merck & Co., Inc. |
High affinity antibody antagonists of interleukin-13 receptor alpha 1
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
RU2015127794A
(ru)
*
|
2007-03-24 |
2018-12-21 |
Касл Терапьютикс, ЭлЭлСи |
Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в
|
CN101067139B
(zh)
*
|
2007-05-14 |
2010-05-26 |
清华大学深圳研究生院 |
一种RNAi载体及其应用
|
CN101619324B
(zh)
*
|
2008-07-01 |
2013-06-26 |
中国疾病预防控制中心病毒病预防控制所 |
复制缺陷型重组腺病毒Ad41载体系统及其应用
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
NO2356135T3
(de)
|
2008-11-05 |
2018-03-24 |
|
|
EP2373338B1
(de)
|
2008-12-03 |
2017-02-15 |
The Johns Hopkins University |
Annexin a2 als immunologisches zielmolekül
|
US20110294870A1
(en)
|
2008-12-04 |
2011-12-01 |
Opko Curna, Llc |
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
AU2010314842A1
(en)
|
2009-11-09 |
2012-05-31 |
Genvec, Inc. |
Methods of propagating monkey adenoviral vectors
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
US9682133B2
(en)
|
2010-03-17 |
2017-06-20 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
WO2012025873A2
(en)
|
2010-08-23 |
2012-03-01 |
Wyeth Llc |
STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
|
PE20140173A1
(es)
|
2010-09-10 |
2014-02-20 |
Wyeth Llc |
Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
EP2654786B1
(de)
|
2010-12-20 |
2019-02-20 |
GenVec, Inc. |
Auf adenovirusvektor basierender impfstoff gegen denguefieber
|
US9063123B2
(en)
|
2011-03-29 |
2015-06-23 |
Dynavax Technologies Corporation |
Transgenic mice expressing human toll-like receptor 8
|
CN102240405A
(zh)
*
|
2011-05-09 |
2011-11-16 |
上海市第十人民医院 |
ApoA-Ⅰmilano基因药物
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
EP2764012B1
(de)
|
2011-10-05 |
2022-02-23 |
GenVec, Inc. |
Adenovirusvektoren und verwendungsverfahren dafür
|
US9580476B2
(en)
|
2011-10-05 |
2017-02-28 |
Genvec, Inc. |
Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
|
BR112014008249B1
(pt)
|
2011-10-05 |
2022-03-15 |
Genvec Inc |
Adenovírus ou vetor adenoviral e composição com os mesmos
|
CN107574154A
(zh)
|
2011-10-05 |
2018-01-12 |
金维克有限公司 |
猴(大猩猩)腺病毒或腺病毒载体及其使用方法
|
CA2861247C
(en)
*
|
2011-12-28 |
2021-11-16 |
Nippon Shinyaku Co., Ltd. |
Antisense nucleic acids
|
WO2013116591A1
(en)
|
2012-02-02 |
2013-08-08 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccine
|
RU2491097C1
(ru)
*
|
2012-02-16 |
2013-08-27 |
Общество с ограниченной ответственностью "НТфарма" |
Фармацевтическая композиция и способ терапии нейродегенеративных заболеваний, в частности бокового амиотрофического склероза
|
SG10201602558UA
(en)
|
2012-03-09 |
2016-05-30 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
EP2855669B1
(de)
|
2012-05-29 |
2018-10-10 |
GenVec, Inc. |
Modifizierte serotyp-28-adenovirusvektoren
|
US9676824B2
(en)
|
2012-05-29 |
2017-06-13 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
WO2014107739A1
(en)
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Antibodies against pcsk9
|
EP2964665B1
(de)
|
2013-03-08 |
2018-08-01 |
Pfizer Inc |
Immunogene fusionspolypeptide
|
EP2968613B1
(de)
|
2013-03-11 |
2019-09-11 |
University of Florida Research Foundation, Inc. |
Freisetzung von card-protein zur behandlung von augenentzündungen
|
CA2923129C
(en)
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3044231B1
(de)
|
2013-09-12 |
2020-08-05 |
BioMarin Pharmaceutical Inc. |
Vektoren des adenoassoziierten virus enthaltend ein faktor-viii gen
|
CA2927968C
(en)
|
2013-10-25 |
2023-02-21 |
Psioxus Therapeutics Limited |
Oncolytic adenoviruses armed with heterologous genes
|
US11053291B2
(en)
|
2014-02-19 |
2021-07-06 |
University Of Florida Research Foundation, Incorporated |
Delivery of Nrf2 as therapy for protection against reactive oxygen species
|
WO2016037154A1
(en)
|
2014-09-04 |
2016-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant hiv-1 envelope proteins and their use
|
WO2016103238A1
(en)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus f proteins and their use
|
EP3247388A1
(de)
|
2015-01-20 |
2017-11-29 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Rekombinantes menschen-/rinder-parainfluenzavirus 3 (b/hpiv3) mit expression eines chimären rsv/bpiv3-f-proteins und verwendungen davon
|
CN107427666B
(zh)
|
2015-01-30 |
2022-11-04 |
加利福尼亚大学校董 |
脊髓软膜下基因递送系统
|
BR112017017460A2
(pt)
|
2015-02-19 |
2018-04-10 |
Pfizer Inc. |
composições de neisseria meningitidis e métodos das mesmas
|
US10301377B2
(en)
|
2015-02-24 |
2019-05-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
PT3288573T
(pt)
|
2015-04-30 |
2020-03-25 |
Psioxus Therapeutics Ltd |
Adenovírus oncolítico que codifica uma proteína b7
|
US20180161455A1
(en)
*
|
2015-06-10 |
2018-06-14 |
American Gene Technologies International, Inc. |
Non-integrating viral delivery system and methods of use therof
|
EP3364985A4
(de)
|
2015-10-19 |
2019-03-27 |
University Of Maryland, Baltimore |
Verfahren zur erzeugung manipulierter dendritischer zelllinien aus menschlichem primärblut
|
AU2016372576A1
(en)
|
2015-12-17 |
2018-06-21 |
Psioxus Therapeutics Limited |
Virus encoding an anti-TCR-complex antibody or fragment
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
DK3402483T3
(da)
|
2016-01-15 |
2024-01-02 |
American Gene Tech Int Inc |
Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler
|
US10888613B2
(en)
|
2016-02-08 |
2021-01-12 |
American Gene Technologies International Inc. |
Method of producing cells resistant to HIV infection
|
WO2017139392A1
(en)
|
2016-02-08 |
2017-08-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
US10808011B2
(en)
|
2016-03-09 |
2020-10-20 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant HIV-1 envelope proteins and their use
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
AU2017241534A1
(en)
|
2016-03-28 |
2018-10-04 |
The Regents Of The University Of California |
Method and composition for treating neuronal hyper-excitability
|
US11560412B2
(en)
|
2016-04-01 |
2023-01-24 |
University Of Maryland, Baltimore |
Compositions comprising GRIM-19 therapeutics and methods of use
|
CA2971303A1
(en)
*
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
JP6971492B2
(ja)
|
2016-07-08 |
2021-11-24 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Hiv予備免疫化および免疫療法
|
JP7176756B2
(ja)
|
2016-07-21 |
2022-11-22 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
パーキンソン病を処置するためのウイルスベクター
|
GB201713765D0
(en)
|
2017-08-28 |
2017-10-11 |
Psioxus Therapeutics Ltd |
Modified adenovirus
|
WO2018054837A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
New ehv insertion site orf70
|
CN109715219B
(zh)
|
2016-09-20 |
2024-03-01 |
勃林格殷格翰动物保健有限公司 |
犬腺病毒载体
|
US10626414B2
(en)
|
2016-09-20 |
2020-04-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Swine influenza vaccine
|
EP3516064A1
(de)
|
2016-09-20 |
2019-07-31 |
Boehringer Ingelheim Vetmedica GmbH |
Neue promotoren
|
US11155832B2
(en)
|
2016-09-30 |
2021-10-26 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into T cells
|
US11602559B2
(en)
|
2016-10-03 |
2023-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV-1 Env fusion peptide immunogens and their use
|
US10960070B2
(en)
|
2016-10-25 |
2021-03-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion coronavirus spike proteins and their use
|
US11147249B2
(en)
|
2016-12-08 |
2021-10-19 |
Alector Llc |
Siglec transgenic mice and methods of use thereof
|
EP3554538A2
(de)
|
2016-12-16 |
2019-10-23 |
Institute for Research in Biomedicine |
Neuartige rekombinante rsv-f-präfusionsproteine und verwendungen davon
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3600405A1
(de)
|
2017-03-24 |
2020-02-05 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Glycanmaskierte manipulierte äussere domänen von hiv-1 gp120 und deren verwendung
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
EP3697440A1
(de)
|
2017-10-16 |
2020-08-26 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Rekombinante hiv-1-hüllproteine und deren verwendung
|
AU2018352236A1
(en)
|
2017-10-16 |
2020-04-23 |
The Curators Of The University Of Missouri |
Treatment of amyotrophic lateral sclerosis (ALS)
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
US11470827B2
(en)
|
2017-12-12 |
2022-10-18 |
Alector Llc |
Transgenic mice expressing human TREM proteins and methods of use thereof
|
CA3092935A1
(en)
|
2018-03-06 |
2019-09-12 |
Precigen, Inc. |
Hepatitis b vaccines and uses of the same
|
US20210361318A1
(en)
|
2018-07-02 |
2021-11-25 |
Voyager Therapeutics, Inc. |
Cannula system and use thereof
|
JP2021529513A
(ja)
|
2018-07-02 |
2021-11-04 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
筋萎縮性側索硬化症および脊髄に関連する障害の治療
|
US20210340188A1
(en)
|
2018-10-22 |
2021-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Recombinant gp120 protein with v1-loop deletion
|
CN110714027A
(zh)
*
|
2019-10-28 |
2020-01-21 |
嘉铭(固安)生物科技有限公司 |
一种表达质粒、用于包装二代腺病毒的细胞株及其应用
|
KR20220140586A
(ko)
|
2020-02-11 |
2022-10-18 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
SARS-CoV-2 백신
|
US11213482B1
(en)
|
2020-03-05 |
2022-01-04 |
University of Pittsburgh—Of the Commonwealth System of Higher Educat |
SARS-CoV-2 subunit vaccine and microneedle array delivery system
|
AU2021357520A1
(en)
|
2020-03-05 |
2022-09-29 |
Neotx Therapeutics Ltd. |
Methods and compositions for treating cancer with immune cells
|
US11773391B2
(en)
|
2020-04-01 |
2023-10-03 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
|
EP4142785A2
(de)
|
2020-04-29 |
2023-03-08 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Rekombinante menschliche metapneumovirus f proteine und deren verwendung
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
WO2022035860A2
(en)
|
2020-08-10 |
2022-02-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replication-competent adenovirus type 4-hiv env vaccines and their use
|
WO2022232648A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion-stabilized lassa virus glycoprotein complex and its use
|
KR20240004764A
(ko)
|
2021-04-30 |
2024-01-11 |
칼리버 임뮤노쎄라퓨틱스, 인크. |
변형된 mhc 발현을 위한 종양용해성 바이러스
|
WO2022235929A1
(en)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Animal model having homologous recombination of mouse pth1 receptor
|
AU2022323509A1
(en)
|
2021-08-03 |
2024-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
US20230277600A1
(en)
|
2021-10-20 |
2023-09-07 |
University Of Rochester |
Treatment Of Age-Related White Matter Loss By Competitive Replacement Of Glial Cells
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023091696A1
(en)
|
2021-11-19 |
2023-05-25 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2023196898A1
(en)
|
2022-04-07 |
2023-10-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Beta globin mimetic peptides and their use
|